Nicholas J. Bass

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Journal: British journal of clinical pharmacology

Published: March 11, 2026

What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review.

What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review.

Journal: Psychiatric genetics

Published: September 12, 2025

Remote, lower-intensity, multidomain lifestyle intervention for subjective cognitive decline or mild cognitive impairment (APPLE-Tree): a multicentre, single-masked, randomised controlled trial.

Remote, lower-intensity, multidomain lifestyle intervention for subjective cognitive decline or mild cognitive impairment (APPLE-Tree): a multicentre, single-masked, randomised controlled trial.

Journal: The lancet. Healthy longevity

Published: July 25, 2025

Immune, Developmental, and Synaptic Pathways Define Bipolar Disorder Clinical Heterogeneity.

Immune, Developmental, and Synaptic Pathways Define Bipolar Disorder Clinical Heterogeneity.

Journal: medRxiv : the preprint server for health sciences

Published: July 16, 2025

Postpartum Psychosis: could genetic vulnerability to insomnia or short sleep duration be protective?

Postpartum Psychosis: could genetic vulnerability to insomnia or short sleep duration be protective?

Journal: Translational psychiatry

Published: June 13, 2025

Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.

Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 23, 2024

Genomics yields biological and phenotypic insights into bipolar disorder.

Genomics yields biological and phenotypic insights into bipolar disorder.

Journal: Nature

Published: December 22, 2023

Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder.

Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder.

Journal: Journal of affective disorders

Published: December 17, 2023

GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.

GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.

Journal: The American journal of psychiatry

Published: October 01, 2023

Genome-wide association study of antisocial personality disorder diagnostic criteria provides evidence for shared risk factors across disorders.

Genome-wide association study of antisocial personality disorder diagnostic criteria provides evidence for shared risk factors across disorders.

Journal: Psychiatric genetics

Published: September 27, 2023

Predicting ADHD in alcohol dependence using polygenic risk scores for ADHD.

Predicting ADHD in alcohol dependence using polygenic risk scores for ADHD.

Journal: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Published: February 02, 2023

The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial.

The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial.

Journal: Trials

Published: April 16, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026